Status:

UNKNOWN

Early rhBNP on Myocardial Remodeling and Reperfusion in Patients With STEMI

Lead Sponsor:

RenJi Hospital

Collaborating Sponsors:

Shanghai 6th People's Hospital

Shanghai Minhang Central Hospital

Conditions:

ST Segment Elevated Myocardial Infarction

Eligibility:

All Genders

18-75 years

Phase:

PHASE4

Brief Summary

The study intends to evaluate the efficacy of early rhBNP on myocardial remodeling and reperfusion in patients with ST-segment elevation myocardial infarction after percutaneous coronary intervention

Detailed Description

As prospectively observational study,it brings anterior acute myocardial infarct patients from 2018 JAN. to 2019 JAN, whose predefined time between symptom onset and percutaneous is not more than 12 h...

Eligibility Criteria

Inclusion

  • Patients are eligible for enrollment if they are suspected as anterior myocardial infarct (anterior myocardial infarct is defined as persistent chest pain for 30 mins at least, with ST-segment elevation of at least 0.2 mV in two or more contiguous precordial leads) within 12 hours after onsets of symptom, and no contraindication for rhBNP. The coronary angiography (CAG) proves left anterior descending (LAD) as culprit vessel, which was totally or nearly occlusion with TIMI 0-1 grade and resulted in TIMI 3 grade after PCI.
  • Exclusive criteria:
  • Killips grade III-IV.
  • unstable hemodynamic; with A-V block or atrial fibrillation;
  • Contraindication of magnetic resonance, such as history of metal, ICD or paceman implant;
  • history of myocardial infarct;
  • pregnancy or breeding;
  • combined with other serious diseases: severe renal dysfunction (creatinine clearance\<30ml/min;), liver failure, neutropenia, thrombocytopenia, acute pancreatitis;
  • life expectancy≤12 months

Exclusion

    Key Trial Info

    Start Date :

    June 19 2019

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 1 2023

    Estimated Enrollment :

    352 Patients enrolled

    Trial Details

    Trial ID

    NCT04033861

    Start Date

    June 19 2019

    End Date

    December 1 2023

    Last Update

    June 1 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Ren Ji Hospital Afflited to School of Medicine, Shanghai Jiao Tong University

    Shanghai, China